4 documents found, page 1 of 1
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Ar...
Aymon, Romain; Mongin, Denis; Guemara, Romain; Salis, Zubeyir; Askling, Johan; Choquette, Denis; Codreanu, Catalin; Di Giuseppe, Daniela; Flouri, IriniFunding Information: Supported by AbbVie, Galapagos, Pfizer, and Eli Lilly. Publisher Copyright: © 2025 The Author(s). Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.; Objective: Our objective was to assess the incidence of major adverse cardiovascular events (MACEs) in patients with rheumatoid arthritis (RA) treated with JAK inhibitors (JAKi), tumor ne...
Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthr...
Ørnbjerg, Lykke M.; Linde, Louise; Georgiadis, Stylianos; Rasmussen, Simon H.; Lindström, Ulf; Askling, Johan; Michelsen, Brigitte; Giuseppe, Daniela DiThe authors regret that the following incorrect values have been published in the original paper: In the abstract: Line 11-12: “age, per year: 0.97 (0.97-0.98)” should be “age, per year: 0.98 (0.97-0.99)” Line 12: “men vs. women: 1.88 (1.60-2.22)” should be “men vs. women: 1.79 (1.51-2.12)” Line 12: “current vs. non-smoking: 0.76 (0.63-0.91)” should be “current vs. non-smoking: 0.72 (0.59-0.87)” Line 12-13: “HL...
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during trea...
Ørnbjerg, Lykke M.; Linde, Louise; Georgiadis, Stylianos; Rasmussen, Simon H.; Lindström, Ulf; Askling, Johan; Michelsen, Brigitte; Giuseppe, Daniela DiFunding Information: LMØ, LL, SG and SHR: research grants from Novartis; UL: none; DDG none; JKW: consultant of AbbVie, Amgen, Celgene, Eli Lilly and Novartis; BG: research grants from Pfizer, Abbvie and BMS; LP: consultant of Novartis Finland, UCB Pharma, Pfizer, Sanofi, BMS, AbbVie, Amgen, Celgene, Eli Lilly, Boehringer-Ingelheim, Mylan; KL: consulting and/or speaking fees from Amgen, Johnson and Johnson and ...
Spectrum of lymphomas across different drug treatment groups in rheumatoid arth...
Mercer, Louise K.; Regierer, Anne C.; Mariette, Xavier; Dixon, William G.; Baecklund, Eva; Hellgren, Karin; Dreyer, Lene; Hetland, Merete LundFunding: Individual registries had entered into agreements with pharmaceutical companies (AbbVie, BMS, Hospira, MSD, Pfizer, Roche, UCB, Samsung and Eli Lilly). The pharmaceutical companies funding these registers were, however, not involved in the planning of the project, the statistical analyses, the interpretation of the results or the decision to publish.; BACKGROUND: Lymphomas comprise a heterogeneous grou...